Racheed Ghanami, MD
Vascular Surgery · Lafayette, LANPI 1326263336
Payments from drug & device makers
What this record shows
Medtronic accounts for 60.4% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2022 at $2,526 and has fallen 94.7% since, to $134 in 2025. That places this record below the midpoint for vascular surgery clinicians in LA, where the typical reported total is $4,548.
Across 64 payments — averaging $71.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Bard Peripheral Vascular, Inc.$977
- Terumo Medical Corporation$175
- Johnson & Johnson$149
- Covidien LP$109
- Cardiovascular Systems Inc.$95
- plus $299 from 9 others
What the payments were for
- Travel & lodging$2,35452%
- Food & beverage$2,19548%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 30 | $2,745 |
| Bard Peripheral Vascular, Inc. | 11 | $977 |
| Terumo Medical Corporation | 1 | $175 |
| Johnson & Johnson | 9 | $149 |
| Covidien LP | 1 | $109 |
| Cardiovascular Systems Inc. | 1 | $95 |
| Angiodynamics, Inc. | 2 | $86 |
| Penumbra, Inc. | 1 | $70 |
| KCI USA, Inc. | 2 | $34 |
| Silk Road Medical, Inc. | 1 | $24 |
| Abbott | 1 | $20 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Inari Medical, Inc. | 1 | $18 |
| Shockwave Medical, Inc | 1 | $15 |
| Artivion, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ELLIPSYS VASCULAR ACCESS SYSTEM$1,707
- WAVELINQ$263
- ENDURANT IIS$195
- Azur CX Detachable$175
- ANGIO-SEAL$175
How this compares
$4,548 in reported general payments places this provider in the 50th percentile of 65 vascular surgery providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 72 | $39,050 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 161 | $1,346 |
| Cilostazol | 59 | $880 |
| ClopidogrelClopidogrel Bisulfate | 71 | $641 |
| Gabapentin | 12 | $433 |
| Tramadol Hcl | 12 | $26 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Lafayette
- Christopher LagraizeLafayette$47K
- Allen BuiLafayette$19K
- Joshua SibilleLafayette$17K
- John LukeLafayette$7K
- Angelle HoganLafayette$6K
- Michael Conners IiiBaton Rouge$70K
- Gregory CrenshawMetairie$67K
- James CravenBaton Rouge$65K
- Marvin WeaverBaton Rouge$58K
- Paul PerkowskiShreveport$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.